Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.

Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, Engholm G, Walsh PM, Jackson C, Vernon S, Morgan E, Gavin A, Morrison DS, Huws DW, Porter G, Butler J, Bryant H, Currow DC, Hiom S, Parkin DM, Sasieni P, Lambert PC, Møller B, Soerjomataram I, Bray F.

Lancet Oncol. 2019 Sep 11. pii: S1470-2045(19)30456-5. doi: 10.1016/S1470-2045(19)30456-5. [Epub ahead of print]

2.

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.

El-Zein M, Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, Colares de Borba P, Teixeira JC, Moscicki AB, Harper DM, Tyring SK, Ramjattan B, Dubin G, Franco EL; HPV-007 Study Group.

Sex Transm Dis. 2019 Oct;46(10):663-669. doi: 10.1097/OLQ.0000000000001053.

PMID:
31464859
3.

Depression and functional status in colorectal cancer patients awaiting surgery: Impact of a multimodal prehabilitation program.

Barrett-Bernstein M, Carli F, Gamsa A, Scheede-Bergdahl C, Minnella E, Ramanakumar AV, Tourian L.

Health Psychol. 2019 Oct;38(10):900-909. doi: 10.1037/hea0000781. Epub 2019 Aug 5.

PMID:
31380686
4.

Supervised exercise training with multimodal pre-habilitation leads to earlier functional recovery following colorectal cancer resection.

Awasthi R, Minnella EM, Ferreira V, Ramanakumar AV, Scheede-Bergdahl C, Carli F.

Acta Anaesthesiol Scand. 2019 Apr;63(4):461-467. doi: 10.1111/aas.13292. Epub 2018 Nov 8.

PMID:
30411316
5.

Towards the validation of a new, blended theoretical model of fear of cancer recurrence.

Lebel S, Maheu C, Tomei C, Bernstein LJ, Courbasson C, Ferguson S, Harris C, Jolicoeur L, Lefebvre M, Muraca L, Ramanakumar AV, Singh M, Parrott J, Figueiredo D.

Psychooncology. 2018 Nov;27(11):2594-2601. doi: 10.1002/pon.4880. Epub 2018 Sep 27.

PMID:
30180279
6.

Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.

Isidean SD, Mayrand MH, Ramanakumar AV, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL; CCCaST Study Group.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):923-929. doi: 10.1158/1055-9965.EPI-16-0705. Epub 2017 Jan 17.

7.

Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.

Tota JE, Jiang M, Ramanakumar AV, Walter SD, Kaufman JS, Coutlée F, Richardson H, Burchell AN, Koushik A, Mayrand MH, Villa LL, Franco EL.

PLoS One. 2016 Dec 22;11(12):e0166329. doi: 10.1371/journal.pone.0166329. eCollection 2016.

8.

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.

Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, de Borba PC, Teixeira JC, Blatter M, Moscicki AB, Harper DM, Romanowski B, Tyring SK, Ramjattan B, Schuind A, Dubin G, Franco EL; HPV-007 Study Group.

BMJ Open. 2016 Aug 26;6(8):e011371. doi: 10.1136/bmjopen-2016-011371. Erratum in: BMJ Open. 2016 Sep 02;6(9):e011371corr1.

9.

Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial.

Isidean SD, Mayrand MH, Ramanakumar AV, Gilbert L, Reid SL, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL; CCCaST Study Group.

Int J Cancer. 2016 Dec 1;139(11):2456-66. doi: 10.1002/ijc.30385. Epub 2016 Aug 30.

10.

Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.

Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Coutlée F, Franco EL.

J Infect Dis. 2016 Sep 1;214(5):676-84. doi: 10.1093/infdis/jiw215. Epub 2016 Jun 2.

11.

The Economic Burden of Schizophrenia in the United States in 2013.

Cloutier M, Aigbogun MS, Guerin A, Nitulescu R, Ramanakumar AV, Kamat SA, DeLucia M, Duffy R, Legacy SN, Henderson C, Francois C, Wu E.

J Clin Psychiatry. 2016 Jun;77(6):764-71. doi: 10.4088/JCP.15m10278.

PMID:
27135986
12.

Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.

Maheu C, Lebel S, Courbasson C, Lefebvre M, Singh M, Bernstein LJ, Muraca L, Benea A, Jolicoeur L, Harris C, Ramanakumar AV, Ferguson S, Sidani S.

BMC Cancer. 2016 Apr 25;16:291. doi: 10.1186/s12885-016-2326-x.

13.

Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.

Shaw E, Ramanakumar AV, El-Zein M, Silva FR, Galan L, Baggio ML, Villa LL, Franco EL; Ludwig-McGill Cohort Study.

BMC Infect Dis. 2016 Mar 8;16:116. doi: 10.1186/s12879-016-1446-x.

14.

Assessment of mediators of racial disparities in cervical cancer survival in the United States.

Sheppard CS, El-Zein M, Ramanakumar AV, Ferenczy A, Franco EL.

Int J Cancer. 2016 Jun 1;138(11):2622-30. doi: 10.1002/ijc.29996. Epub 2016 Jan 29.

15.

Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques.

Rabinovich A, Bernard L, Ramanakumar AV, Stroian G, Gotlieb WH, Lau S, Bahoric B.

Curr Oncol. 2015 Dec;22(6):405-11. doi: 10.3747/co.22.2727.

16.

Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.

Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P.

J Med Econ. 2016;19(3):292-303. doi: 10.3111/13696998.2015.1117979. Epub 2015 Nov 30.

PMID:
26618853
17.

Virtual reality robotic surgery simulation curriculum to teach robotic suturing: a randomized controlled trial.

Kiely DJ, Gotlieb WH, Lau S, Zeng X, Samouelian V, Ramanakumar AV, Zakrzewski H, Brin S, Fraser SA, Korsieporn P, Drudi L, Press JZ.

J Robot Surg. 2015 Sep;9(3):179-86. doi: 10.1007/s11701-015-0513-4. Epub 2015 May 16.

PMID:
26531197
18.

HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.

Richardson LA, El-Zein M, Ramanakumar AV, Ratnam S, Sangwa-Lugoma G, Longatto-Filho A, Cardoso MA, Coutlée F, Franco EL; PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium.

Cancer Cytopathol. 2015 Dec;123(12):745-54. doi: 10.1002/cncy.21596. Epub 2015 Jul 31.

19.

Para-aortic and Pelvic Radiotherapy, an Effective and Safe Treatment in Advanced-stage Uterine Cancer.

Rabinovich A, Bernard L, Niazi TM, Ramanakumar AV, Gotlieb WH, Lau S, Bahoric B.

Anticancer Res. 2015 May;35(5):2893-900.

PMID:
25964573
20.

Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study.

Rabinovich A, Ramanakumar AV, Lau S, Gotlieb WH.

Acta Obstet Gynecol Scand. 2015 Jul;94(7):776-780. doi: 10.1111/aogs.12642. Epub 2015 Apr 28.

PMID:
25923364
21.

Sexual transmission of oral human papillomavirus infection among men.

Dahlstrom KR, Burchell AN, Ramanakumar AV, Rodrigues A, Tellier PP, Hanley J, Coutlée F, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2959-64. doi: 10.1158/1055-9965.EPI-14-0386. Epub 2014 Nov 12.

22.

Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens.

Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Koushik A, Mayrand MH, Coutlée F, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):286-90. doi: 10.1158/1055-9965.EPI-14-0566. Epub 2014 Oct 2.

23.

Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.

Louvanto K, Franco EL, Ramanakumar AV, Vasiljević N, Scibior-Bentkowska D, Koushik A, Cuzick J, Coutlée F, Lorincz AT; Biomarkers of Cervical Cancer Risk Study Team.

Int J Cancer. 2015 Mar 15;136(6):E638-45. doi: 10.1002/ijc.29196. Epub 2014 Sep 19.

24.

Prospective quality of life outcomes following robotic surgery in gynecologic oncology.

Abitbol J, Lau S, Ramanakumar AV, Press JZ, Drummond N, Rosberger Z, Aubin S, Gotlieb R, How J, Gotlieb WH.

Gynecol Oncol. 2014 Jul;134(1):144-9. doi: 10.1016/j.ygyno.2014.04.052. Epub 2014 May 4.

PMID:
24796633
25.

HPV testing with cytology triage for cervical cancer screening in routine practice.

Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A.

Am J Obstet Gynecol. 2014 May;210(5):474.e1-7. doi: 10.1016/j.ajog.2013.12.033. Epub 2013 Dec 25.

PMID:
24373948
26.

Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.

de Araujo-Souza PS, Ramanakumar AV, Candeias JM, Thomann P, Trevisan A, Franco EL, Villa LL; Ludwig–McGill Cohort Study.

BMC Infect Dis. 2014 Nov 18;14:578. doi: 10.1186/s12879-014-0578-0.

27.

Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions.

Rodrigues-Coutlée C, Archambault J, Money D, Ramanakumar AV, Raboud J, Hankins C, Koushik A, Richardson H, Brassard P, Franco EL, Coutlée F; Canadian Women's HIV Study Group.

J Clin Virol. 2013 Dec;58(4):660-5. doi: 10.1016/j.jcv.2013.10.015. Epub 2013 Oct 17.

PMID:
24210329
28.

Lung cancer screening: review and performance comparison under different risk scenarios.

Tota JE, Ramanakumar AV, Franco EL.

Lung. 2014 Feb;192(1):55-63. doi: 10.1007/s00408-013-9517-x. Epub 2013 Oct 24. Review.

PMID:
24153450
29.

Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.

Trevisan A, Schlecht NF, Ramanakumar AV, Villa LL, Franco EL; Ludwig-McGill Study Group.

J Gen Virol. 2013 Aug;94(Pt 8):1850-7. doi: 10.1099/vir.0.051722-0. Epub 2013 May 15.

30.

Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection.

Oliveira LB, Louvanto K, Ramanakumar AV, Franco EL, Villa LL; Ludwig–McGill Cohort Study.

J Gen Virol. 2013 Aug;94(Pt 8):1858-64. doi: 10.1099/vir.0.052811-0. Epub 2013 May 15.

31.

Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.

Tota JE, Ramanakumar AV, Jiang M, Dillner J, Walter SD, Kaufman JS, Coutlée F, Villa LL, Franco EL.

Am J Epidemiol. 2013 Aug 15;178(4):625-34. doi: 10.1093/aje/kwt018. Epub 2013 May 9.

32.

Assessment of the performance of algorithms for cervical cancer screening: evidence from the Ludwig-McGill cohort study.

Chevarie-Davis M, Ramanakumar AV, Ferenczy A, Villa LL, Franco EL; Ludwig–McGill Cohort Study.

Gynecol Oncol. 2013 Mar;128(3):415-9. doi: 10.1016/j.ygyno.2012.12.008. Epub 2012 Dec 9.

33.

Cervical human papillomavirus detection is not affected by menstrual phase.

Tota JE, Ramanakumar AV, Mahmud SM, Trevisan A, Villa LL, Franco EL; Ludwig-McGill Cohort Study Group.

Sex Transm Infect. 2013 May;89(3):202-6. doi: 10.1136/sextrans-2012-050610. Epub 2012 Oct 30.

34.

Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.

Ribeiro RJ, Monteiro CP, Azevedo AS, Cunha VF, Ramanakumar AV, Fraga AM, Pina FM, Lopes CM, Medeiros RM, Franco EL.

PLoS One. 2012;7(6):e39236. doi: 10.1371/journal.pone.0039236. Epub 2012 Jun 29.

35.

Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.

Gilbert L, Basso O, Sampalis J, Karp I, Martins C, Feng J, Piedimonte S, Quintal L, Ramanakumar AV, Takefman J, Grigorie MS, Artho G, Krishnamurthy S; DOvE Study Group.

Lancet Oncol. 2012 Mar;13(3):285-91. doi: 10.1016/S1470-2045(11)70333-3. Epub 2012 Jan 17.

PMID:
22257524
36.

Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.

Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E, Roger M; Biomarkers of Cervical Cancer Risk Study Team.

Int J Cancer. 2012 Aug 1;131(3):E312-9. doi: 10.1002/ijc.27356. Epub 2012 Jan 3.

37.

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.

Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.

J Med Virol. 2011 Jun;83(6):1034-41. doi: 10.1002/jmv.22081.

PMID:
21503917
38.

Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence.

Ferguson R, Ramanakumar AV, Richardson H, Tellier PP, Coutlée F, Franco EL, Roger M.

Hum Immunol. 2011 Apr;72(4):337-41. doi: 10.1016/j.humimm.2011.01.010. Epub 2011 Jan 20.

PMID:
21256910
39.

Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community.

Sangwa-Lugoma G, Ramanakumar AV, Mahmud S, Liaras J, Kayembe PK, Tozin RR, Lorincz A, Franco EL.

Sex Transm Dis. 2011 Apr;38(4):308-15. doi: 10.1097/OLQ.0b013e3181fc6ec0.

PMID:
21150817
40.

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Ramanakumar AV, Goncalves O, Richardson H, Tellier P, Ferenczy A, Coutlée F, Franco EL.

BMC Infect Dis. 2010 Nov 11;10:326. doi: 10.1186/1471-2334-10-326.

41.

Clinical significance of molecular biomarkers in glioblastoma.

Ang C, Guiot MC, Ramanakumar AV, Roberge D, Kavan P.

Can J Neurol Sci. 2010 Sep;37(5):625-30.

PMID:
21059509
42.

Exposures in painting-related occupations and risk of lung cancer among men: results from two case-control studies in Montreal.

Ramanakumar AV, Parent MÉ, Richardson L, Siemiatycki J.

Occup Environ Med. 2011 Jan;68(1):44-51. doi: 10.1136/oem.2009.049957. Epub 2010 Sep 4.

PMID:
20817942
43.

Are endometrial polyps true cancer precursors?

Perri T, Rahimi K, Ramanakumar AV, Wou K, Pilavdzic D, Franco EL, Gotlieb WH, Ferenczy A.

Am J Obstet Gynecol. 2010 Sep;203(3):232.e1-6. doi: 10.1016/j.ajog.2010.03.036. Epub 2010 May 15.

PMID:
20478550
44.

Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection.

Ramanakumar AV, Thomann P, Candeias JM, Ferreira S, Villa LL, Franco EL.

J Clin Microbiol. 2010 Mar;48(3):791-6. doi: 10.1128/JCM.00844-09. Epub 2010 Jan 6.

45.

Exposures in painting related occupations and risk of selected cancers: results from a case-control study in Montreal.

Ramanakumar AV, Nadon L, Siemiatycki J.

Am J Ind Med. 2008 Jun;51(6):419-27. doi: 10.1002/ajim.20564.

PMID:
18324661
46.
47.

Risk of lung cancer following exposure to carbon black, titanium dioxide and talc: results from two case-control studies in Montreal.

Ramanakumar AV, Parent ME, Latreille B, Siemiatycki J.

Int J Cancer. 2008 Jan 1;122(1):183-9.

48.

Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada.

Ramanakumar AV, Parent ME, Siemiatycki J.

Am J Epidemiol. 2007 Mar 15;165(6):634-42. Epub 2006 Dec 22.

PMID:
17189590
49.

Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada.

Ramanakumar AV, Parent ME, Menzies D, Siemiatycki J.

Lung Cancer. 2006 Jul;53(1):5-12. Epub 2006 Jun 2.

PMID:
16733074
50.

Coping mechanisms among long-term survivors of breast and cervical cancers in Mumbai, India.

Ramanakumar AV, Balakrishna Y, Ramarao G.

Asian Pac J Cancer Prev. 2005 Apr-Jun;6(2):189-94.

Supplemental Content

Loading ...
Support Center